Mandating limits on acetaminophen in combination opioid products does not decrease incidence of hepatotoxicity

被引：0
|
作者：
Goldberger, David [1 ]
Vearrier, David [1 ]
机构：
[1] Drexel Univ, Coll Med, Dept Emergency Med, Philadelphia, PA 19104 USA
来源：
CLINICAL TOXICOLOGY | 2016年 / 54卷 / 08期
关键词：
acetaminophen; hepatotoxicity; opioid;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
236
引用
收藏
页码：768 / 768
页数：1
相关论文
共 12 条
  • [1] FDA limits acetaminophen in prescription combination products
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (04) : 476 - 476
  • [2] Removal of Opioid/Acetaminophen Combination Prescription Pain Medications: Assessing the Evidence for Hepatotoxicity and Consequences of Removal of These Medications
    Michna, Edward
    Duh, Mei Sheng
    Korves, Caroline
    Dahl, June L.
    PAIN MEDICINE, 2010, 11 (03) : 369 - 378
  • [3] ACETAMINOPHEN COMPLICATIONS BEFORE VS AFTER FDA MANDATE TO LIMIT ACETAMINOPHEN DOSE IN PRESCRIPTION COMBINATION OPIOID PRODUCTS
    Orandi, Babak
    McLeod, Chandler
    Lee, William M.
    Karvellas, Constantine J.
    McGuire, Brendan M.
    Lewis, Cora E.
    Terrault, Norah
    Locke, Jayme E.
    HEPATOLOGY, 2022, 76 : S1234 - S1234
  • [4] Risk of Hepatotoxicity-Related Hospitalizations among Patients Treated with Opioid/Acetaminophen Combination Prescription Pain Medications
    Duh, Mei-Sheng
    Vekeman, Francis
    Korves, Caroline
    Lefebvre, Patrick
    Dial, Ellison
    Latremouille-Viau, Dominick
    Wei, Robert S.
    Stangle, Bruce E.
    Lafeuille, Marie-Helene
    Michna, Edward
    Greenberg, Paul E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S43 - S43
  • [5] Risk of Hepatotoxicity-Related Hospitalizations among Patients Treated with Opioid/Acetaminophen Combination Prescription Pain Medications
    Duh, Mei Sheng
    Vekeman, Francis
    Korves, Caroline
    Lefebvre, Patrick
    Dial, Ellison
    Latremouille-Viau, Dominick
    Wei, Robert S.
    Stangle, Bruce E.
    Lafeuille, Marie-Helene
    Michna, Edward
    Greenberg, Paul E.
    PAIN MEDICINE, 2010, 11 (11) : 1718 - 1725
  • [6] The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period
    Cepeda, MS
    Africano, JM
    Manrique, AM
    Fragoso, W
    Carr, DB
    PAIN, 2002, 96 (1-2) : 73 - 79
  • [7] Paracetamol (Acetaminophen)-Related Deaths Reported to United States Poison Centers: Paracetamol Single Ingredient Products and Paracetamol-opioid Combination Products
    Green, J. L.
    Dart, R. C.
    CLINICAL TOXICOLOGY, 2010, 48 (03) : 275 - 276
  • [8] Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
    Orandi, Babak J.
    McLeod, M. Chandler
    MacLennan, Paul A.
    Lee, William M.
    Fontana, Robert J.
    Karvellas, Constantine J.
    McGuire, Brendan M.
    Lewis, Cora E.
    Terrault, Norah M.
    Locke, Jayme E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 735 - 744
  • [9] Association of FDA Mandate Limiting Acetaminophen in Prescription Combination Opioid Products and Subsequent Hospitalizations, Acute Liver Failure, and Liver Transplant
    Orandi, B.
    McLeod, C.
    MacLennan, P.
    Lee, W.
    Fontana, R.
    Karvellas, C.
    McGuire, B.
    Lewis, C.
    Terrault, N.
    Locke, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S607 - S607
  • [10] The combination of low dose of naloxone and morphine in patient-controlled (PCA) does not decrease opioid requirements in the postoperative period
    Mehlisch, DR
    PAIN, 2003, 101 (1-2) : 209 - 211
12